| Corey Crumpton, | |
|
315 Hospital Dr, Madison, TN 37115-5030 | |
| (615) 732-7662 | |
| Not Available |
| Full Name | Corey Crumpton |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - Critical Care Medicine |
| Location | 315 Hospital Dr, Madison, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063280915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0200X | Registered Nurse - Critical Care Medicine | 917012 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Corey Crumpton, 315 Hospital Dr, Madison, TN 37115-5030 Ph: (615) 732-7662 | Corey Crumpton, 315 Hospital Dr, Madison, TN 37115-5030 Ph: (615) 732-7662 |
News Archive
Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.
Elsevier's Journal of Clinical Virology in collaboration with the US Centers for Disease Control and Prevention (CDC) today announced the publication of a special supplement entitled 'Update on HIV Diagnostic Testing Algorithms'.
Scientists at Oregon Health & Science University, Stanford University, University of Valencia and IGENOMIX have discovered that chromosomal abnormalities in human embryos created for in vitro fertilization, or IVF, can be predicted within the first 30 hours of development at the cell-1 stage which results from the union of a female egg and male sperm.
The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies to reduce drug cost burdens after joining the clinical trial, according to a study led by researchers at Dana-Farber Cancer Institute in Boston.
Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy-harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.
› Verified 6 days ago
Patrick Grant Moss, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 | |
Carson Stafford, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 | |
Mr. Timothy Bulso, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-868-6503 | |
Hayden Wood, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 | |
Krupa Master, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 | |
Angelica Ian Cabrera Bautista, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 | |
Leah R Olley, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 Hospital Dr, Madison, TN 37115 Phone: 615-732-7662 |